Aptevo Therapeutics

(NASDAQ) APVO

Current Price$4.48

Market Cap$5.57M

Since IPO (2016)-100%

5 Year-100%

1 Year-92%

1 Month-11%

Aptevo Therapeutics Financials at a Glance

Market Cap

$5.57M

Revenue (TTM)

$0.00

Net Income (TTM)

-$26.26M

EPS (TTM)

-$203.74

P/E Ratio

-0.02

Dividend

$0.00

Beta (Volatility)

1.21 (Average)

Dividend

$0.00

Beta (Volatility)

1.21 (Average)

Price

$4.48

Volume

18,769.229

Open

$4.34

Price

$4.48

Volume

18,769.229

Open

$4.34

Previous Close

$4.47

Daily Range

$4.34 - $4.58

52-Week Range

$3.80 - $59.40

Estimated Earnings Date

Aug 10, 2026

Dividend

$0.00

Beta (Volatility)

1.21 (Average)

Price

$4.48

Volume

18,769.229

Open

$4.34

Previous Close

$4.47

Daily Range

$4.34 - $4.58

52-Week Range

$3.80 - $59.40

Estimated Earnings Date

Aug 10, 2026

APVO News

Aptevo Reports 85% Remission in Q2

Motley Fool Markets TeamAug 11, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aptevo Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Marvin L. White, MBA

Website

www.aptevotherapeutics.com

Headquarters

Seattle, WA 98121, US

APVO Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-198.50%

Return on Capital

-119.55%

Return on Assets

-131.93%

Earnings Yield

-50.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.57M

Shares Outstanding

1.25M

Volume

18.77K

Avg. Volume

33.29K

Financials (TTM)

Gross Profit

-$116.00K

Operating Income

-$26.67M

EBITDA

-$26.04M

Operating Cash Flow

-$26.98M

Capital Expenditure

$0.00

Free Cash Flow

-$26.98M

Cash & ST Invst.

$14.53M

Total Debt

$4.42M

Aptevo Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$35.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$5.57M

N/A

Market Cap/Employee

$150.54K

N/A

Employees

N/A

Net Income

-$6.70M

-4.5%

EBITDA

-$6.66M

-5.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$14.53M

+579.1%

Total Debt

$4.42M

+0.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$3.53M

-20.2%

Short Term Debt

$892.00K

N/A

Return on Assets

-1.32%

N/A

Return on Invested Capital

-1.76%

N/A

Free Cash Flow

-$7.97M

-21.1%

Operating Cash Flow

-$7.97M

-21.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RADXRadiopharm Theranostics Limited

RADXRadiopharm Theranostics Limited$4.37+2.82%

BCDABioCardia, Inc.

BCDABioCardia, Inc.$1.20+0.84%

ERNAErnexa Therapeutics Inc.

ERNAErnexa Therapeutics Inc.$6.27-6.48%

EPIXESSA Pharma Inc.

EPIXESSA Pharma Inc.$0.20-1.85%

HCWBHCW Biologics Inc.

HCWBHCW Biologics Inc.$4.30-6.11%

ABPAbpro Corporation

ABPAbpro Corporation$0.52+0.00%

CEROCERo Therapeutics Holdings, Inc.

CEROCERo Therapeutics Holdings, Inc.$0.01+15.38%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92-0.01%

TAT&T

TAT&T$20.58+0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.30-0.15%

CLROClearOne

CLROClearOne$6.48+1.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

ONDSOndas

ONDSOndas$7.41-0.06%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$39.95+0.05%

Questions About APVO

What is the current price of Aptevo Therapeutics?

Aptevo Therapeutics is trading at $4.47 per share.

What is the 52-week range for Aptevo Therapeutics?

Over the past 52 weeks, Aptevo Therapeutics has traded between $3.80 and $59.40.

How much debt does Aptevo Therapeutics have?

As of the most recent reporting period, Aptevo Therapeutics reported total debt of $4.42M.

How much cash does Aptevo Therapeutics have on hand?

Aptevo Therapeutics reported $14.53M in cash and cash equivalents in its most recent financial results.

What is Aptevo Therapeutics’s dividend yield?

Aptevo Therapeutics does not currently have a dividend yield.

Aptevo Therapeutics

Aptevo Therapeutics Financials at a Glance

APVO News

Aptevo Reports 85% Remission in Q2

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Aptevo Therapeutics

APVO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Aptevo Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About APVO

What is the current price of Aptevo Therapeutics?

What is the 52-week range for Aptevo Therapeutics?

How much debt does Aptevo Therapeutics have?

How much cash does Aptevo Therapeutics have on hand?

What is Aptevo Therapeutics’s dividend yield?

Premium Investing Services